Drreddys Laboratories reported $193M in Interest Expense on Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Ani Pharmaceuticals ANIP:US $ 2.53M 77K
Aphria Inc APH:CN C$ 10.45M 3.97M
Aurora Cannabis Inc ACB:CN 15.88M 1.11M
Canopy Growth Corp WEED:CN C$ 24.56M 19.81M
Catalent CTLT:US $ 31.9M 5M
Drreddys Laboratories RDY:US $ 193M 104M
Endo International Ordinary Shares ENDP:US $ 141.64M 6.95M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
JAZZ PHA JAZZ:US $ 69.82M 41.24M
Lannett LCI:US $ 13.22M 0.59M
Lonza Group LONN:SW 29M 7M
Novartis NOVN:VX 201M 1000K
Pacira Pharmaceuticals PCRX:US $ 7.02M 0.05M
Phibro Animal Health PAHC:US $ 3.03M 0.05M
Prestige Brands PBH:US $ 15.08M 3.91M
Richter Gedeon RICHT:HB 154M 13M
Supernus Pharmaceuticals SUPN:US $ 5.47M 0.4M
Teva Pharmaceutical TEVA:IT 240M 1000K